Research and Markets Logo
DUBLIN, August 2, 2013 /PRNewswire/ --
Research and Markets
(http://www.researchandmarkets.com/research/kz7r4k/pain_management) has announced the addition of the "Pain Management Devices - Global Strategic Business Report" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
This report analyzes the worldwide markets for Pain Management Devices in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 29 companies including many key and niche players such as Boston Scientific Corporation, Codman & Shurtleff, Inc., DJO Global, Inc., Kimberly-Clark Corporation, Bio-Medical Research (BMR) Ltd., Medtronic, Inc., NeuroTherm, Smiths Medical, St. Jude Medical, Inc., and Stryker Corporation.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. Executive Summary
1. INDUSTRY OVERVIEW
- Ineffective Pain Management Treatment Options: A Cause of Concern
- Current State of Pain Management: An Insight
- Pain Management Devices: A Prelude
- Will Containment of Healthcare Cost Influence Pain Management Devices Market?
- US Leads the Pain Management Devices Market
- Developing Economies More than a Blip on the Radar
2. MARKET TRENDS/DRIVERS & ISSUES
- Ageing Population Offers Significant Market Opportunity
- Neuropathic Pain: A Highly Underserved Market
- Oncologic Pain: Another Potential Market for Pain Management Devices
- Reducing Risk of Infection: An Important Factor to Increase the Adoption Rate of Implantable Devices
- Emphasis on Reduced Hospital Stays Pushes Up Demand for Pain Management Devices
- PNS: A Potential Lucrative Area for Developing Pain Management Devices
- Reimbursement Policy Impacts the Uptake of Pain Management Devices
- Product Complexity: A Cause of Concern
3. MARKET OVERVIEW FOR SELECT PAIN MANAGEMENT DEVICES
- Electrical Stimulators
- Implantable Neurostimulation Devices: The Future of Pain Management?
- Spinal Cord Stimulation (SCS): A Rapidly Evolving Market
- Occipital Nerve Stimulation: An Untapped Market with Potentia
- Will TENS Continues to Register Favorable Growth?
- Analgesia Infusion Pumps
- Analgesia Infusion Pumps: Continue to Register Favorable Growth
- Smart Pump Technology: A Major Growth Driver
- Equipment Recalls Cast a Long Shadow of Worry
4. PRODUCT OVERVIEW
5. SELECT PAIN MANAGEMENT DEVICE APPROVALS
- Myoscience Obtains FDA Approval for New Pain Management Device
- Nevro Obtains FDA Approval to Start SENZA-RCT Clinical Trial
- Medasys Obtains PMA Approval from FDA for Prometra®
- Boston Scientific Obtains CE Mark Approval for Infinion16 Percutaneous Lead
- Boston Scientific Obtains FDA Approval for Infinion16 Percutaneous Lead
- Medtronic Receives FDA Approval for New Neurostimulation System
- St. Jude Medical Obtains FDA Approval for Epiducer Neurostimulation Delivery System
- St. Jude Medical Receives European CE Mark Approval for Penta Surgical Lead
- Wellness Pro 2010 ® Micro Current Frequency Generator Receives FDA Approval
6. PRODUCT INNOVATIONS/INTRODUCTIONS
- Bio-Medical Research Introduces Neurotech Recovery Device
- DJO Global Unveils OA Nano Knee Brace
- Smiths Medical Unveils CADD®-Solis System with PIB
- DJO Global Introduces Empi Active Knee Transcutaneous TENS System
- Boston Scientific Introduces D4 and W4 Spinal Cord Stimulation Lead Splitters
- Competitive Technologies Commercially Launches Calmare®
7. RECENT INDUSTRY ACTIVITY
- Kimberly-Clark Takes Over Pain Management Division of Baylis Medical
- Competitive Technologies and Calmare® Scrambler Therapy® Extend Agreement
- Amerinet Signs Agreement with MMJ Labs
- Meridian Health System Forms Joint Mobile Health Venture with Cypak
- St Jude Medical Inks Agreement with Greatbatch Medical
- NeuroTherm Acquires Smith & Nephews Interventional Spine Pain Management Assets
8. FOCUS ON SELECT PLAYERS
9. GLOBAL MARKET PERSPECTIVE
III. MARKET
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. LATIN AMERICA
7. REST OF WORLD
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 29 (including Divisions/Subsidiaries - 34)
- The United States (25)
- Europe (8)
- - France (1)
- - The United Kingdom (2)
- - Italy (1)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (1)
For more information visit http://www.researchandmarkets.com/research/kz7r4k/pain_management.
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals
SOURCE Research and Markets
Source: www.prnewswire.com
No comments:
Post a Comment